Post-COVID-19 Pulmonary Fibrosis: The Rationale of Mesenchymal Stem Cell Transplantation for Lung Regeneration. Biomed. Res. Ther. 2022, 9 (5), 5075-5083. https://doi.org/10.15419/bmrat.v9i5.741.